In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Victory Pharma Inc.

www.victorypharma.com

Latest From Victory Pharma Inc.

Post-Marketing Progress: Drug Industry Is Meeting Phase IV Commitments, FDA Says

FDA’s John Jenkins disputes accusations that the pharmaceutical industry does not take post-marketing studies seriously and that the agency is lax on enforcement. According to updated data from FDA, Phase IV studies are being completed in a timely manner, Jenkins argues – and when they aren’t, the agency is taking action.

BioPharmaceutical Post Market Regulation & Studies

Egalet Lines Up Cash In Deal With Japan’s Shionogi Ahead Of IPO

The specialty pharma will receive $10 million upfront from Shionogi in exchange for rights to multiple oral abuse-deterrent hydrocodone opioid products. The Japanese pharma also agreed to buy $15 million in stock to close with Egalet’s IPO.

BioPharmaceutical Japan

Egalet Lines Up Cash In Deal With Shionogi Ahead Of IPO

The specialty pharma will receive $10 million upfront from Shionogi in exchange for rights to multiple oral abuse-deterrent hydrocodone opioid products. The Japanese pharma also agreed to buy $15 million in stock to close with Egalet’s IPO.

BioPharmaceutical Deals

FDA’s Postmarketing Powers Force Shionogi To Withdraw Rybix ODT

Agency says Shionogi’s orally disintegrating tramadol is misbranded because the firm did not submit a post-marketing trial protocol in time, but the company states the trial is not worth the expense and will withdraw the product.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Victory Pharma Inc.
  • Senior Management
  • Matt Heck, Pres. & CEO
    Mike Goolsby, VP, Sales
    Thomas Heck, VP, Bus. Dev.
    Daniel Stokely, Chief Accounting Officer
  • Contact Info
  • Victory Pharma Inc.
    Phone: (858) 720-4500
    11682 El Camino Real
    Ste. 250
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register